Here's What Key Metrics Tell Us About Techne (TECH) Q1 Earnings

05.11.25 15:30 Uhr

Techne (TECH) reported $286.56 million in revenue for the quarter ended September 2025, representing a year-over-year decline of 1%. EPS of $0.42 for the same period compares to $0.42 a year ago.The reported revenue represents a surprise of -0.96% over the Zacks Consensus Estimate of $289.34 million. With the consensus EPS estimate being $0.42, the company has not delivered EPS surprise.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Techne performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Organic Growth: -1% versus 1.1% estimated by two analysts on average.Net Sales- Protein Sciences: $202.2 million versus the two-analyst average estimate of $208.25 million. The reported number represents a year-over-year change of -1.1%.Net Sales- Diagnostics and Spatial Biology: $79.5 million compared to the $80.65 million average estimate based on two analysts. The reported number represents a change of -4.4% year over year.View all Key Company Metrics for Techne here>>>Shares of Techne have returned +3.2% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bio-Techne Corp (TECH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Techne Corp.

Wer­bung

Analysen zu Techne Corp.

DatumRatingAnalyst
09.08.2006Update Techne Corp.: OutperformLeerink Swann
03.03.2005Update Techne Corp.: OutperformRobert W. Baird
DatumRatingAnalyst
09.08.2006Update Techne Corp.: OutperformLeerink Swann
03.03.2005Update Techne Corp.: OutperformRobert W. Baird
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Techne Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen